Five companies given go-ahead for IPO.
Market regulator Securities and Exchange Board of India (SEBI) on Wednesday cleared initial public offerings (IPOs) of four more companies. Prestige Hospitality Ventures, an arm of realty firm Prestige Estates Projects, Anand Rathi Share and Stock Brokers, Epack Prefab Technologies and Gujarat Kidney and Super Speciality have received final observation from SEBI to launch IPO.
Prestige Hospitality Ventures eyes ₹2,700 crore IPO that comprises a fresh issue of ₹1,700 crore and an offer-for-sale (OFS) worth ₹1,000 crore, according to its draft red herring prospectus (DRHP). Prestige Estates Projects will offoload shares in the OFS.
₹750-cr IPO from Anand Rathi
Anand Rathi Share and Stock Brokers is planning to launch ₹745 crore IPO, which is entirely a fresh issue. Anand Rathi Group’s brokerage arm, Anand Rathi Share and Stock Brokers, has refiled its DRHP with SEBI. Earlier, it had filed its DRHP in December 2024. Proceeds worth ₹550 crore will be used to fund the company’s long-term working capital requirements and general corporate purposes, it said in a DRHP.
Epack Prefab public issue
Epack Prefab Technologies’ IPO consists of fresh issues worth ₹300 crore and an offer-for-sale of up to one crore shares by promoter group and selling shareholders. The company will use the funds for setting up a new manufacturing facility at Ghiloth Industrial Area in Alwar, Rajasthan, expansion of the existing manufacturing facility at Mambattu in Andhra Pradesh, payment of debt and for general corporate purposes.
Gujarat Kidney IPO
Gujarat Kidney and Super Speciality’s offer is entirely a fresh issue of 2.2 crore shares. It provides integrated healthcare services, with a focus on secondary and tertiary care. Proceeds of the IPO will be used for proposed acquisition of Parekhs Hospital in Ahmedabad, part-payment of purchase consideration for the already acquired Ashwini Medical Centre, setting up a new hospital in Vadodara, and buying robotics equipment for the hospital in Vadodara. Besides, the company will also use fresh funds for debt repayment, funding inorganic growth through unidentified acquisitions and general corporate purposes.
Published on August 6, 2025
